Old Web
English
Sign In
Acemap
>
authorDetail
>
Ishwarya Murali
Ishwarya Murali
Broad Institute
Chronic lymphocytic leukemia
Cancer research
MAPK/ERK pathway
PI3K/AKT/mTOR pathway
Medicine
3
Papers
11
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Abstract 1097: Mechanisms of primary and acquired resistance to venetoclax in chronic lymphocytic leukemia (CLL)
2021
Cancer Research
Ishwarya Murali
Justin Cha
Ignaty Leshchiner
Yanan Kuang
Kevin A Vasquez
Jasneet Kaur Khalsa
Stacey M. Fernandes
Filippo Utro
Kahn Rhrissorrakrai
Chaya Levovitz
Brian P. Danysh
Kara Slowik
Raquel A. Jacobs
Cloud P. Paweletz
Laxmi Parida
Gad Getz
Jennifer R. Brown
Show All
Source
Cite
Save
Citations (0)
Activation of the MAPK pathway mediates resistance to PI3K inhibitors in chronic lymphocytic leukemia (cll).
2021
Blood
Ishwarya Murali
Siddha Kasar
Aishath Naeem
Svitlana Tyekucheva
Jasneet Kaur Khalsa
Emily M Thrash
Gilad Itchaki
Dimitri Livitz
Ignaty Leshchiner
Shuai Dong
Stacey M. Fernandes
Gad Getz
Amy J. Johnson
Jennifer R. Brown
Show All
Source
Cite
Save
Citations (5)
Activating MAPK Pathway Mutations Mediate Primary Resistance to PI3K Inhibitors in Chronic Lymphocytic Leukemia (CLL)
2018
Blood
Ishwarya Murali
Siddha Kasar
Emily M. McWilliams
Gilad Itchaki
Svitlana Tyekucheva
Dimitri Livitz
Ignaty Leshchiner
Shuai Dong
Stacey M. Fernandes
Gad Getz
Amy J. Johnson
Jennifer R. Brown
Show All
Source
Cite
Save
Citations (6)
1